Thus, some hypothesize that NSCLC patients with EGFR mutation and brain metastases could receive EGFR-TKI alone first, and brain RT may be delayed until tumor progression on brain imaging or symptomatic progression, thereby delaying radiation-related neurotoxicitis [12, 13]. Here, EGFR is linked to neoplasm.